Polen Capital acquired 20.5k Mirum Pharmaceuticals shares worth $1.93M. That's 0.01% of their equity portfolio (108th largest holding). The first Mirum Pharmaceuticals trade was made in Q2 2025. Since then Polen Capital bought shares two more times and sold shares on one occasions. The stake costed the investor $1.24M, netting the investor a gain of 55% so far.
… Selling at Mirum Pharmaceuticals In other Mirum Pharmaceuticals news, SVP Jolanda … on Mirum Pharmaceuticals About Mirum Pharmaceuticals (Free Report) Miru...
Benzinga Pro data, Mirum Pharmaceuticals (NASDAQ: MIRM ) reported Q4 sales of $27.91 million. Earnings fell to a loss of $36.43 million, resulting in a 2.03%...
Keybanc boosted Five Below, Inc. (NASDAQ: FIVE ) price target from $188 to $200. Keybanc analyst Bradley Thomas maintained an Overweight rating on the stock....
According to Benzinga Pro data, during Q2, Mirum Pharmaceuticals (NASDAQ: MIRM ) posted sales of $17.48 million. Earnings were up 26.45%, but Mirum Pharmaceu...